| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis | US905128 | 1997-08-01 | US5910308A | 1999-06-08 | Arthur H. K. D'Jang |
| Provided is an herbal extract-based composition comprising an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida (hawthorn leaves or berries), and an extract of Camellia sinensis (green tea). Also provided is a process for preparing a herbal extract-based composition which comprises separately extracting each of hawthorn berries, green tea leaves, and Gynostemma pentaphyllum leaves; drying extraction eluates obtained from the extracting of each of hawthorn berries, green tea leaves, and Gynostemma pentaphyllum leaves to obtain organic residues in forming a hawthorn berry extract powder, green tea extract powder, and a Gynostemma pentaphyllum extract powder; and combining the green tea extract powder, the Gynostemma pentaphyllum extract powder, and the hawthorn berry extract powder in desired proportions to form the herbal extract-based composition which has health promoting effects including potent inhibition of free radicals. | ||||||
| 2 | Galenic composition | US309482 | 1994-09-22 | US5482712A | 1996-01-09 | Moon H. Kim; Chan K. Park; Oh H. Kwon |
| The galenic composition of this invention has been found to possess valuable pharmacological properties in the prevention and treatment of the aftereffects related to ingesting excessive amount of ethanol. The inventive composition decreases blood alcohol concentration by stimulating the alcohol metabolism and reduces the increased content of neutral fat in the blood due to alcohol intake. The composition comprises puerariae radix, phaseoli radiati semen, small red bean, crataegi fructus, malt, cnidii rhizoma, atractylodes rhizoma, cassiae semen, amomi semen, menthae folium and fructose. In the galenic composition of the present invention puerariae radix, phaseoli radiati semen, small red bean, crataegi fructus, malt, cnidii rhizoma, atractylodes rhizoma, cassiae semen, amomi semen, menthae folium and fructose is present preferably in the weight ratio of 20-50:20-50:20-50: 10-25:10-25:10-25:10-25:10-25:3-7:1-5:200-300, respectively. | ||||||
| 3 | Pharmaceutical compositions and methods for protecting and treating sun damaged skin | US790190 | 1997-01-29 | US5804168A | 1998-09-08 | Howard Murad |
| This invention relates to a pharmaceutical composition for the protection and prevention of skin damage to a patient resulting from exposure to sunlight having at least one antioxidant component in an amount sufficient to inhibit the formation of free radicals; at least one anti-inflammatory component in an amount sufficient to substantially inhibit the inflammation associated with exposure to sunlight; and at least one immunity boosting component to enhance the patient's immune response. In a preferred form, the composition also includes a cysteine component, a magnesium component, a manganese component, a copper component, a selenium component, and a carotenoid component. In a more preferred form the invention also includes wild yam root, wild yam extract, yellow dock, bupleurum, poria cocos, gentian root, myrrh gum, hawthorn berry extract, and rosemary extract. The invention also relates to a method for protecting skin from damage caused by exposure to sunlight by administering the pharmaceutical composition in an amount therapeutically effective in increasing the sun protection factor of the skin. | ||||||
| 4 | Skin regenerating composition and a process for the preparation thereof | US356221 | 1982-03-08 | US4601905A | 1986-07-22 | Lajos Szeles |
| A process for the preparation of a skin-regenerating or skin-protecting pharmaceutical composition is disclosed wherein the flower, root, fruit or cortex of a plant selected from the group consisting of Fugaceae, Caesalpiniaceae, Chenopodiaceae, and Rosaceae is extracted with ethanol at a temperature of 0.degree. to 50.degree. C. The obtained plant extract is purified and the dry substance content thereof is adjusted to 0.01 to 0.1% by adding more of the ethanol. | ||||||
| 5 | Therapeutic composition with marked polydetoxifying properties, especially with regard to tobacco | US457634 | 1974-04-03 | US4057620A | 1977-11-08 | Robert Louis Prugnaud |
| A therapeutic detoxifying composition comprising a sympathoparalytic, vitamins from the groups B and C, and an organic salt of quinine. The composition may also contain an endogenous detoxifying substance. A preferred composition comprises Muramidase, nicotinamide, thiamine, ascorbic acid, pyridoxine, and a quinine salt having an organic anion, optionally with a sympathoparalytic sedative such as the dry extract of Crataegus root, all in specified proportions. The composition may be formulated with pharmaceutically acceptable carriers, and is markedly effective in detoxification therapy for solanaceous and ganglioplegic toxins such as nicotine and related toxic compounds. | ||||||
| 6 | Glycosidal material having activity on the heart and vascular vessels and its preparation from plant sources | US50003655 | 1955-04-07 | US2799618A | 1957-07-16 | THEODOR BERSIN; ARTHUR MUELLER |
| 7 | Therapeutic composition | US342247 | 1999-06-29 | US6093404A | 2000-07-25 | Maha Kattan |
| A therapeutic composition and a method of use therefor in adults and children are disclosed. The therapeutic composition alleviates symptoms associated with attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) including hyperactivity, impulsivity, and inattentiveness. The therapeutic composition contains proanthocyanidin, yucca root, hawthorn berry, bilberry, silymarin complex, and ginkgo biloba. The therapeutic composition is taken in a single daily dose. | ||||||
| 8 | Herbal combinations | US736392 | 1996-10-24 | US5958417A | 1999-09-28 | Chau-shin Hsu |
| Herbal combinations which reduce serum cholesterol and triglyceride levels comprise (1) herbs having substantial recognized activity in enhancing circulatory function (ECF herbs) and (2) herbs having substantial recognized effects in promoting bowel motility (PBM herbs). Preferred combinations have a combined total of at least 16% (dry weight basis) of at least two ECS herbs in combination with a combined total of at least 16% (dry weight basis) of at least two PBM herbs. Particularly preferred combinations are selected from the following herbs: Crataegus, Ho Shou Wu, Chrysanthemum, Lotus Leaf, Alisma and Hu-Zhang, Cassia Seed, and Rhubarb. | ||||||
| 9 | Preparations of Crataegus species, pharmaceutical compositions and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions | US592333 | 1996-01-29 | US5925355A | 1999-07-20 | Shyam Sunder Chatterjee; Hermann Ernst Jaggy |
| The preparation of a total extract of leaves and flowers of appropriate Crataegus species is described as well as three new fractions of said total extract and their use as pharmaceutical compositions for preventing sudden death due the cardiac arrest and reperfusion-caused cardiovascular lesions and other reperfusion-caused life-threatening pathological conditions. | ||||||
| 10 | Method and compositions for lowering blood lipids | US235550 | 1994-04-29 | US5665359A | 1997-09-09 | Walter Kwok Keung Ho; Hson-Mou Chang; Chi-Ming Lee |
| It has been discovered that the Chinese fruit known as shanzha, and extracts and purified component derived therefrom, can be administered orally to animals to reduce levels of cholesterol in the blood. The mechanism of action is believed to include the "up-regulation" of LDL receptors on cell surfaces and inhibition of transcription factors for sterol responsive genes. Examples demonstrate the isolation of active components and extracts, potential mechanisms of action in animals and cell culture, and conditions promoting retention of activity during storage. | ||||||
| 11 | Therapeutical composition | US360935 | 1973-05-16 | US4104373A | 1978-08-01 | Richard Sichert |
| Therapeutical compositions useful against congestions in the lymphatic system and comprising alkaloid-containing and/or glycoside-containing extracts of Umbelliferae, Liliaceae, Berberidaceae and Solanaceae plants and of Digitalis, Strophanthus, Convallaria or Crataegus plants and including the alkaloids, glycosides and salts of those plants. | ||||||
| 12 | Circulatory adjuvant shell elements for cardiac glycoside suppository cores | US1099660 | 1960-02-25 | US3122475A | 1964-02-25 | HEINRICH SCHAEPPI JOHANN |
| 13 | Stable aqueous medicinal solutions | US71040758 | 1958-01-22 | US3035975A | 1962-05-22 | HANS VOIGT |
| 14 | 血清高密度リポタンパク質(HDL)濃度を著しく増加させる漢方薬複合組成物及び製造方法 | JP2016537097 | 2014-06-12 | JP6273017B2 | 2018-01-31 | ガオ ヂュゥァンツン; ガオ シィァンユー |
| 15 | アテローム性動脈硬化症などの心血管障害の処置のためのピクノジェノールまたはブドウ種子などのプロアントシアニジンとCentellaasiaticaとの組み合わせ | JP2012524326 | 2010-08-11 | JP5711231B2 | 2015-04-30 | ベルカーロ ジャンニ; ブルキ カロライナ; フェラーリ ヴィクトール |
| 16 | Antioxidant nutrients supplement composition for smokers and former smokers, and a method for manufacturing | JP2006065013 | 2006-03-10 | JP4943023B2 | 2012-05-30 | 善 浩 朴; 浩 宰 李 |
| 17 | Compositions and methods for promoting and maintaining the production of neurotransmitters | JP2004532915 | 2003-08-18 | JP4719832B2 | 2011-07-06 | ウィリアム イー． シェル，; エリザベス エイチ． チャルバストラ， |
| 18 | healthy food | JP2000397334 | 2000-12-27 | JP4553224B2 | 2010-09-29 | 孝雄 大長 |
| 19 | Composition and method for promoting and maintaining production of neurotransmitter | JP2010079658 | 2010-03-30 | JP2010189404A | 2010-09-02 | SHELL WILLIAM E; CHARUVASTRA ELISABETH H |
| <P>PROBLEM TO BE SOLVED: To provide a composition and a method which increasingly produce a specific neurotransmitter. <P>SOLUTION: A precursor of the neurotransmitter is oral administrated with a natural vegetable substance which stimulates uptake of the neurotransmitter precursor, and at the same time a natural vegetable substance for activating adenylate cyclase is added in order to avoid attenuation and also prevent pharmacological resistance so that synthesis and release of the neurotransmitter are increased. The composition for a medical food is so designed as to increase recognition force, induce sleep, increase a sub-sympathy autonomic nerve function, improve a balance of autonomic nerve, increase production of NO, decrease a blood pressure, increase a blood flow, and treat viral infection. The composition includes an amino acid such as choline, a drug plant such as Ginkgo biloba and the other food such as cocoa. <P>COPYRIGHT: (C)2010,JPO&INPIT | ||||||
| 20 | メタボリックシンドローム改善・予防組成物 | JP2007537744 | 2006-09-29 | JPWO2007037438A1 | 2009-04-16 | 二郎 高橋; ホセイン ガージ; 潮 三川; 博三 後藤 |
| 高コレステロール症、高トリグリセリド症、耐糖能異常、高血圧、肥満はそれぞれの症状が軽度であっても、これらが複合的に発生するメタボリックシンドロームが、大きな死亡要因の1つである循環器疾患の原因となっている。アスタキサンチン含有抽出を有効成分として含有するメタボリックシンドロームの改善・予防効果を有する組成物ならびにアスタキサンチン含有抽出を有効成分として含有するメタボリックシンドロームの飲食物や医薬品を提供する。また、アスタキサンチン含有抽出はメタボリックシンドロームの症状である高血圧、高脂血、糖尿病、肥満の改善・予防にも効果がある。 | ||||||
QQ群二维码
意见反馈
意见反馈